Panama · Spanish · MINSA
MINSA translation, built for Panamanian regulatory review.
What Panama's Ministerio de Salud (MINSA) expects from Spanish clinical trial and registration documentation — and how an Amavita pilot delivers a package aligned to Panamanian regulatory usage.
What this covers
MINSA in three moving parts.
What must be in Panamanian Spanish
Protocol, informed consent, investigator's brochure, safety narratives, and labeling — using Panamanian medical terminology and patient-facing language.
Certification and legalization
Legal instruments require a traductor público autorizado licensed in Panama and, for foreign public documents, apostille under the Hague Convention.
Where submissions stall
Inconsistent INN usage, ICFs written above the expected reading level, and missing appendix translations trigger requerimientos from MINSA evaluators.
What must be in Panamanian Spanish
Protocol, informed consent, investigator's brochure, safety narratives, and labeling — using Panamanian medical terminology and patient-facing language.
Certification and legalization
Legal instruments require a traductor público autorizado licensed in Panama and, for foreign public documents, apostille under the Hague Convention.
Where submissions stall
Inconsistent INN usage, ICFs written above the expected reading level, and missing appendix translations trigger requerimientos from MINSA evaluators.
How MINSA compares to the rest of the world.
MINSA does not set its rules in isolation. Our primary-source review of preclinical translation requirements across nine LATAM regulators places Panama on the same three-tier map used above, so you can see where MINSA is stricter — and where it is more permissive — than its neighbours.
Outside the region the picture changes again. The companion study of preclinical translation rules at eight non-LATAM regulators, from FDA and EMA to PMDA, NMPA, MHRA, Health Canada, TGA and Swissmedic found no primary instrument requiring visual replication of a Module 4 study report, which is why the sworn-translation ceiling described on this page is a LATAM-native construct.
If you are budgeting a multi-country programme, read the three-tier framework for MINSA preclinical translation in the LATAM regulator study before deciding what to translate for Panama.
Ready to scope your Panama pilot?
Start the pilot form and get a timeline in 2 business days.
Frequently asked
MINSA translation, quick answers.
What language does MINSA require for clinical trial submissions in Panama?
MINSA reviews clinical trial dossiers in Spanish. Protocols, informed consent forms, investigator's brochures, safety narratives, and product labeling must be translated into Panamanian Spanish, with source-language documents accepted only when paired with a compliant translation.
Who certifies translations for MINSA submissions?
Legal instruments require a traductor público autorizado licensed in Panama and, for foreign public documents, apostille or equivalent legalization. Technical documents should be prepared by qualified medical translators reviewed by clinicians familiar with Panamanian regulatory usage.
How does the Amavita pilot cover MINSA submissions?
A pilot scopes one Panamanian protocol or dossier, delivers an MD-reviewed Spanish package aligned to MINSA expectations, and includes a pre-submission QC checklist covering terminology, ICF readability, and legalization workflow.
Next step
Scope a Panama pilot this quarter.
Share your Panama protocol or registration dossier. Our team will reach out within 2 business days with a scoped pilot proposal and timeline.